Prophylactic Oral Ganciclovir Compared With Deferred Therapy For Control Of Cytomegalovirus In Renal Transplant Recipients1, 2

DC Brennan, KA Garlock, GG Singer… - …, 1997 - journals.lww.com
Background. Treatment with prophylactic oral acyclovir, intravenous ganciclovir, or
immunoglobulins to prevent cytomegalovirus (CMV) infection and disease in renal …
被引用次数：173 相关文章

Prophylactic oral ganciclovir compared with deferred therapy for control of cytomegalovirus in renal transplant recipients

DC Brennan, KA Garlock, GG Singer… - …, 1997 - profiles.wustl.edu
Background. Treatment with prophylactic oral acyclovir, intravenous ganciclovir, or
immunoglobulins to prevent cytomegalovirus (CMV) infection and disease in renal …

Prophylactic oral ganciclovir compared with deferred therapy for control of cytomegalovirus in renal transplant recipients

DC Brennan, KA Garlock, GG Singer… - …, 1997 - pure.johnshopkins.edu
Background. Treatment with prophylactic oral acyclovir, intravenous ganciclovir, or
immunoglobulins to prevent cytomegalovirus (CMV) infection and disease in renal …

[引用][C] Prophylactic oral ganciclovir compared with deferred therapy for control of cytomegalovirus in renal transplant recipients

DC BRENNAN, KA GARLOCK, GA STORCH… - …, 1997 - pascal-francis.inist.fr
Prophylactic oral ganciclovir compared with deferred therapy for control of cytomegalovirus
in renal transplant recipients CNRS Inist Pascal-Francis CNRS Pascal and Francis …

Prophylactic oral ganciclovir compared with deferred therapy for control of cytomegalovirus in renal transplant recipients

DC Brennan, KA Garlock, GG Singer… - …, 1997 - pubmed.ncbi.nlm.nih.gov
Background Treatment with prophylactic oral acyclovir, intravenous ganciclovir, or
immunoglobulins to prevent cytomegalovirus (CMV) infection and disease in renal …

Prophylactic oral ganciclovir compared with deferred therapy for control of cytomegalovirus in renal transplant recipients.

DC Brennan, KA Garlock, GG Singer… - …, 1997 - europepmc.org
Background Treatment with prophylactic oral acyclovir, intravenous ganciclovir, or
immunoglobulins to prevent cytomegalovirus (CMV) infection and disease in renal …